Business Context and Reporting Period
Company: Abbott Laboratories
Filing Type: Form 8-K (Current Report)
Date of Report: December 9, 2005
Subject: Entry into a Material Definitive Agreement regarding amendments to executive benefit plans.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on legal and compliance amendments to benefit plans.
Material Changes
On December 9, 2005, Abbott Laboratories amended its 401(k) Supplemental Plan and Supplemental Pension Plan to comply with Internal Revenue Code Section 409A. Key changes include:
- Elimination of Thresholds: The plans previously required accrued benefits to reach minimum thresholds ($50,000 for the 401(k) Supplemental Plan and $100,000 for the Supplemental Pension Plan) before distribution to grantor trusts. These thresholds have been removed.
- Compliance Driver: Section 409A permits distributions only in limited circumstances, excluding the achievement of a minimum benefit threshold.
- Benefit Impact: The amendments do not alter the amount of benefits paid to participants or the form of funding.
Outlook, Risks, and Unusual Items
Tax Implications: Vested plan benefits that had not yet reached the previous thresholds, as well as vested benefits accrued through December 31, 2005 (to the extent not previously funded), will be distributed to participants' grantor trusts. These amounts must be included by participants in their income for the 2005 tax year.
Exhibits: The full text of the amended plans is filed as Exhibits 10.1 and 10.2.
Investor Verification Checklist
- Review Exhibits 10.1 and 10.2 for the complete legal text of the amended plans.
- Confirm the specific tax treatment of the 2005 income inclusion for affected participants.
- Verify that no other material agreements or financial events were omitted from this specific 8-K filing.